Poseida Therapeutics Inc.

09/12/2024 | Press release | Distributed by Public on 09/12/2024 17:01

Poseida Therapeutics Highlights Positive Interim Phase 1 Results for P-BCMA-ALLO1 and Preclinical Data for Dual CAR-T P-CD19CD20-ALLO1 at the 66th American Society of[...]